Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Price

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2014
Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malariaS G Zaloumis, J Tarning, S Krishna, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivaxA R Hasugian, E Tjitra, A Ratcliff, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparumU Lek-Uthai, R Suwanarusk, R Ruengweerayut, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2014
Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malariaS G Zaloumis, J Tarning, S Krishna, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivaxA R Hasugian, E Tjitra, A Ratcliff, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparumU Lek-Uthai, R Suwanarusk, R Ruengweerayut, et al.
Pageof 4